MarginsXMarginsX
Home › Markets › Health Care › MBRX

Moleculin Biotech Inc. (MBRX)

MBRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$7.14
-9.28% on the day
Market cap
$7.6M
Nano cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$33.6M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1659617/000143774926008841/0001437749-26-008841-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMBRX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2016
SEC CIK0001659617
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$33.6M
Operating income-$25.1M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$8.9M
Total assets$22.1M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
3.4 months
$7.3M cash at June 30, 2026
Share count, 1 year
+942.5%
2025-11-07 to 2026-11-06 · +26607.1% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt regarding the Company's ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$7.3M cash; operating cash flow -$6.3M a quarter.Report 2026-06-30
Shares outstanding1,061,533 (2026-11-06); 50,910,476 a year earlier; 29,810,443 three years earlier. 1y figure adjusted for splits (1-for-500 overall); 3y figure adjusted for splits (1-for-7500 overall).Cover page 2026-11-06
Reverse splits, 3 years3; latest 1-for-20 on 2026-10-20Source 2026-10-20
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-08-21
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-09-18
AuditorGrant Thornton LLP, Ft. Lauderdale, Florida, United StatesPCAOB Form AP 2026-03-25
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$0-$7.6M-$6.7M$7.3MNo debt tags$010-Q 2026-08-13
Q1 2026
2026-03-31
$0-$12.8M-$6.1M$10.3MNo debt tags$010-Q 2026-05-14
Q4 2025
2025-12-31
$0$15.6M-$5.4M$8.9MNo debt tags$010-K 2026-03-18
Q3 2025
2025-09-30
$0-$25.4M-$7.2M$6.7MNo debt tags$010-Q 2025-11-13
Q2 2025
2025-06-30
$0-$17.8M-$5.6M$7.6MNo debt tags$010-Q 2026-08-13
Q1 2025
2025-03-31
$0-$5.9M-$4.6M$7.7MNo debt tags$010-Q 2026-05-14
Q4 2024
2024-12-31
$0-$6.6M-$5.1M$4.3MNo debt tags$010-K 2026-03-18
Q3 2024
2024-09-30
$0-$7.0M-$6.1M$9.4MNo debt tags$010-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52026-08-21
Latest annual report
FORM 10-K/A
10-K/A2026-04-14
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-13
Latest current report
FORM 8-K
8-K2026-11-16
Latest proxy
FORM DEFA14A
DEFA14A2026-08-24

Source: SEC EDGAR submissions feed, 846 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-9.5%
1 month-9.5%
3 months-31.1%
Year to date+137.8%
1 year-30.7%
From 52-week high-91.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
UPCUniverse Pharmaceuticals Inc.$1.48-1.99%$7.4M
GTBPGT Biopharma Inc.$3.54-1.81%$7.3M
CURXCuranex Pharmaceuticals Inc$4.63-0.11%$7.3M
IMRNImmuron Limited$0.8996+2.23%$7.3M
LGVNLongeveron Inc.$2.14-14.06%$7.2M
ENSCEnsysce Biosciences Inc.$0.4095-2.13%$8.0M
RKTORocket One Inc.$0.3210+0.03%$8.0M
MTVAMetaVia Inc.$1.21-7.31%$8.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier